Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 20, 2022
Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?Guadalupe Garis, Michael Haupts, Thomas Duning, et al.Dementia and Geriatric Cognitive Disorders Extra|May 3, 2013
Cognitive profiles of patients with mild cognitive impairment or dementia in Alzheimer's or Parkinson's diseaseHelmut Hildebrandt, Frauke Fink, Andreas Kastrup, et al.European Neurology|May 11, 2016
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis SpasticityMichael Haupts, Carlos Vila, Anna Jonas, et al.BMC Medical Genetics|May 25, 2002
PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patientsBianca Miterski, Eckhart Sindern, Michael Haupts, et al.Electrophoresis|July 27, 2004
Refining the results of a whole-genome screen based on 4666 microsatellite markers for defining predisposition factors for multiple sclerosisRené Gödde, Viktoria Nigmatova, Peter Jagiello, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|December 10, 2013
Faith as a resource in patients with multiple sclerosis is associated with a positive interpretation of illness and experience of gratitude/aweArndt Büssing, Anne-Gritli Wirth, Knut Humbroich, et al.Frontiers in Neurology|August 1, 2018
Salivary IL-1ß as an Objective Measure for Fatigue in Multiple Sclerosis?Katrin Hanken, Carina Sander, Lara Qaiser, et al.Journal of Negative Results in Biomedicine|September 7, 2005
An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factorsRené Gödde, Stefanie Brune, Peter Jagiello, et al.Free Neuropathology|October 20, 2023
Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroidsLidia Stork, Michael Haupts, Niels Kruse, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2024
Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional StudyLeila Husseini, Jakob Jung, Natalie Boess, et al.Pageof 2